North Carolina

North Carolina

NO
Registered Patient Population
0%
of Total Population Represented by Patients
N/A
Average Price Per 1/8
N/A
Average Price Per Gram Cannabis Oil
0
Total Medical Retail Locations Currently in Operation
N/A
Ratio of Patients to Retail Location

North Carolina’s program limits patients to cannabidiol preparations with 0.3 percent or less THC, in compliance with USDA hemp standards. The state has yet to authorize CBD product production or distribution. The state provides for no method of safe and legal access.

Patient Rights and Civil Protection 37/100   
Arrest Protection 20/40
Affirmative Defense 7/15
Parental Rights Protections 0/10
DUI Protections 0/5
Employment Protections 0/5
Explicit Privacy Standards 5/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 5/5
Organ Transplants 0/5
Reciprocity 0/3
Access to Medicine 11/100   
Allows Distribution Programs 0/40
– Allows Access to Dried Flowers 0/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 0/5
– Allows for a Reasonable Number of Dispensaries 0/5
– Does Not Require Vertical Integration 0/2
– Ownership/Employment Restrictions 0/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 0/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 3/10
Does not Impose Bans or Limits on THC 1/10
Does not Impose Bans on CBD 7/10
Local Bans/Zoning 0/10
Comprehensive Qualifying Conditions 20/50
Adding New Conditions 0/10
– Law/Regulations Allow for New Conditions 0/5
– System Works for Adding New Conditions 0/5
Reasonable Access for Minors 6/10
Reasonable Caregiver Background Checks 4/4
Number of Caregivers 1/2
Patient/Practitioner-Focused Task Force or Advisory Board 0/2
Reasonable Fees (Patients and Caregivers) 9/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 3/5
Does Not Classify Cannabis as a Medicine of Last Resort 3/5
Functionality 25/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 0/50
No Significant Administrative or Supply Problems 8/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 7/10
Reasonable Possession Limits 5/5
Reasonable Purchase Limits 0/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 2/7
Consumer Safety and Provider Requirements 24.34/100   
Dispensing 5.67/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility Sanitary Conditions 0/1.25
– Storage Protocols 0/1.25
– Reasonable Security Protocols 0/1.25
– Inventory Control 0/1.25
Recall Protocol and Adverse Event Reporting 0/5
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency/Compound Identification 1/1.67
Required Testing 3/5
– Active Compound Identification 1/1.67
– Contaminants 1/1.67
– Potency 1/1.67
Grow/Cultivation 8/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0/0.71
– Reasonable Security Protocols 0/0.71
– Batch and Lot Tracking 0/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 0/5
– Pesticide Guidance 0/2.5
– Pesticide Labeling 0/2.5
Required Testing 3/5
– Active Ingredient Identification 1/1.25
– Contaminants 1/1.25
– Potency 1/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 5/5
Manufacturing 10.67/25
Staff Training 0/5
Standard Operating Procedures 0/5
– Facility and Equipment Sanitary Conditions 0/1
– Workforce Safety Protocols 0/1
– Storage Protocols 0/1
– Reasonable Security Protocols 0/1
– Batch and Lot Tracking 0/1
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency and Compound Information 1/1.67
Required Testing 3/5
– Active Ingredient Identification 1/1
– Contaminants 1/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 5/5
Laboratory Operations 0/25
Staff Training 0/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 0/5
Independent or Third Party 0/5
Standard Operating Procedures and Protocols 0/5
– Equipment and Instrument Calibration 0/0.83
– Sample Tracking 0/0.83
– Facility and Equipment Sanitary Conditions 0/0.83
– Disposal/Waste 0/0.83
– Storage Protocols 0/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 0/20   
Delivery Available? 0/6
Curbside Pickup Available? 0/2
Medical Cannabis Essential? 0/7
Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

North Carolina Medical Marijuana Laws and Regulations

North Carolina’s medical marijuana law took effect in July 2014, creating a pilot program that authorizes research on “hemp extract” for the purpose of treating intractable epilepsy. Diagnosed patients must be under the care of a state-approved neurologist who has attempted three or more failed treatment options. This section includes a brief summary of the law and links to general resources for patients, caregivers and physicians.

Becoming a Patient in North Carolina

To become a medical cannabis patient in North Carolina, a person must be diagnosed by a neurologist with intractable epilepsy. Patients and caregivers are only protected for use and possession of lab-certified extracts that cannot produce psychoactive effects. This section includes an overview of state requirements for qualifying patients and links to other helpful resources.

Recommending Cannabis in North Carolina

Licensed neurologists who are affiliated with one of four select Universities, can obtain state approval for a pilot study. Registered physicians are exempt from all criminal and civil penalties under North Carolina law. This section includes an overview of state requirements and links to other medical information.

Becoming a Caregiver, Producer, or Provider in North Carolina

The caregiver must complete the Caregiver Registration Application and return to DHHS.

The State of Medical Marijuana in North Carolina

The State of Medical Marijuana in North Carolina